NCT05275478 2026-04-15Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Terminated110 enrolled
NCT01743950 2026-03-25A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With BevacizumabUniversity of Wisconsin, MadisonPhase 2 Terminated49 enrolled 19 charts